Top in ID: Persistent COVID-19 symptoms, RCT assesses transmission risk

Researchers found that most patients recovering from COVID-19 had at least one persistent symptom, the most common being shortness of breath or dyspnea, exhaustion or fatigue and sleep disorders, according to an analysis of 45 studies.

A report on the data was the top story in infectious disease last week.

Another top story was about a study that showed participants who attended a 5-hour indoor concert wearing N95 masks did not contract COVID-19 at a higher rate than a control group, despite a lack of social distancing measures.

Read these and more top stories in infectious disease below:

More than 70% of COVID-19 patients experience at least one persistent symptom

More than 70% of patients who have recovered from COVID-19 experience at least one persistent symptom for at least 60 days, according to the results of a systematic review recently published in JAMA Network Open. Read more.

Under strict safety measures, no participants in staged concert got COVID-19

Under strict safety measures, no participants in a staged concert were infected with SARS-CoV-2, according to researchers, who said their experiment was the first randomized clinical trial to assess the risk of COVID-19 at mass gatherings. Read more.

FDA authorizes lower dose of Regeneron antibody cocktail for COVID-19

The FDA has authorized a lower dose of Regeneron’s antibody cocktail to treat COVID-19, which the company said may help more patients access the treatment. Read more.

FDA tells J&J to discard more batches of vaccine from Baltimore plant

The FDA has told Johnson & Johnson that more batches of COVID-19 vaccine produced at a plant under scrutiny for its manufacturing practices must be discarded. Read more.

More hospitals mandate COVID-19 vaccination for employees

The first hospital system in the country to mandate COVID-19 vaccination for employees said this week that it had suspended nearly 180 personnel without pay for not getting vaccinated. Read more.